Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature
- 25 July 2011
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 52 (1), 48-54
- https://doi.org/10.1111/j.1537-2995.2011.03254.x
Abstract
Autoimmune hemolytic anemia (AIHA) occurring after solid organ transplantation is an infrequently reported entity. We describe in this report six cases of AIHA in pediatric liver or combined liver and small bowel transplant patients. We retrospectively identified and reviewed the records of pediatric liver or combined liver and small bowel transplant patients with both serologic and clinical evidence of AIHA. We also performed an English language literature review for prior publications of AIHA occurring after solid organ transplantation. We identified six patients presenting with severe hemolysis 9 months to 14 years after transplantation. All six developed warm AIHA, and two had concomitant cold agglutinins. All except one patient received various therapeutic combinations including steroids, intravenous immune globulin, rituximab, plasmapheresis, splenectomy, and vincristine. Five patients achieved remission 2 weeks to 3 months after presentation. Although tacrolimus has been speculated to play a causative role in the development of AIHA after organ transplantation, our case series demonstrated slightly better outcomes despite continuing tacrolimus compared to published cases where most patients either received significantly reduced doses of tacrolimus or were switched to a different immunosuppressant (83% vs. 76% cumulative literature remission rate). AIHA may occur in solid organ transplant patients at a much higher frequency than previously believed. Hemolysis is often severe and resistant to steroid treatment alone. Thus early diagnosis and institution of aggressive multimodality treatment, including the use of rituximab, may be needed to achieve remission.This publication has 19 references indexed in Scilit:
- Severe autoimmune hemolytic anemia in a liver transplanted childPediatric Transplantation, 2008
- Rituximab therapy for cytomegalovirus-associated auto-immune hemolytic anemia in a liver-transplant recipientTransplant International, 2008
- Cold agglutinin syndrome in pediatric liver transplant recipientsPediatric Transplantation, 2007
- Severe cold agglutinin disease caused by recurrent monomorphic Epstein–Barr virus (EBV)‐associated post‐transplant lymphoproliferative disorder (PTLD), clonally related to an EBV‐negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipientPediatric Transplantation, 2007
- Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non‐malignant diseasesBritish Journal of Haematology, 2004
- Severe hemolytic anemia related to production of cold agglutinins following living donor liver transplantation: a case reportTransplantation Proceedings, 2003
- Rituximab for Immune Hemolytic Anemia following T- and B-Cell-Depleted Hematopoietic Stem Cell TransplantationActa Haematologica, 2002
- Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantationBone Marrow Transplantation, 1999
- Hemolysis associated with transplantationTransfusion, 1998
- Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplantBone Marrow Transplantation, 1997